VALIANT LABORATORIES
|
VALIANT LABORATORIES Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Profit Before Tax | ₹-1.51 Cr | ₹-0.77 Cr | ₹38 Cr |
| Adjustment | ₹4.29 Cr | ₹2.04 Cr | ₹1.56 Cr |
| Changes In working Capital | ₹-3.93 Cr | ₹-0.37 Cr | ₹25 Cr |
| Cash Flow after changes in Working Capital | ₹-1.15 Cr | ₹0.90 Cr | ₹65 Cr |
| Cash Flow from Operating Activities | ₹1.31 Cr | ₹1.89 Cr | ₹56 Cr |
| Cash Flow from Investing Activities | ₹-53 Cr | ₹-144 Cr | ₹-55 Cr |
| Cash Flow from Financing Activities | ₹45 Cr | ₹152 Cr | ₹-0.93 Cr |
| Net Cash Inflow / Outflow | ₹-6.80 Cr | ₹10 Cr | ₹-0.05 Cr |
| Opening Cash & Cash Equivalents | ₹12 Cr | ₹1.26 Cr | ₹1.31 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - |
| Closing Cash & Cash Equivalent | ₹4.92 Cr | ₹12 Cr | ₹1.26 Cr |
Compare Cashflow Statement of peers of VALIANT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VALIANT LABORATORIES | ₹360.4 Cr | -4.8% | -24.6% | -33.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹439,378.0 Cr | 2.8% | 6.7% | 2.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,996.0 Cr | 1.9% | -0.5% | 6.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,959.0 Cr | 0.1% | 3.4% | 15.8% | Stock Analytics | |
| CIPLA | ₹123,666.0 Cr | 1.8% | -3.2% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,008.0 Cr | 2.7% | 0.4% | 3.4% | Stock Analytics | |
VALIANT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VALIANT LABORATORIES | -4.8% |
-24.6% |
-33.6% |
| SENSEX | 0.6% |
1.3% |
7% |
You may also like the below Video Courses